Richner J, Schuff-Werner P, Bätge R, Beyer J H, Nagel G A
Klin Wochenschr. 1987 Apr 15;65(8):353-8. doi: 10.1007/BF01745571.
Serum factors may be responsible for reduced host-anti-tumor defence. Although there is still confusion about their origin, attempts have been made to immobilize serum components by Protein A columns as a therapeutic modality. In our study the in vitro adsorption of 90% of the IgG from cancer sera on "immobilized protein A" did not influence the inhibitory serum activity as measured in a mixed lymphocyte culture. Therefore, IgG or immune complexes do not seem to be the suppressive serum factor in patients with advanced colorectal carcinoma. There is evidence for leakage of small amounts of protein A from the columns which have immunostimulatory activity. Perhaps this may explain necrosis after a therapeutic immunoadsorption.
血清因子可能是宿主抗肿瘤防御能力降低的原因。尽管其来源仍不明确,但已有人尝试用蛋白A柱固定血清成分作为一种治疗方式。在我们的研究中,“固定化蛋白A”对癌血清中90%的IgG进行体外吸附,并未影响混合淋巴细胞培养中所测得的血清抑制活性。因此,IgG或免疫复合物似乎并非晚期结直肠癌患者血清中的抑制因子。有证据表明,柱体中有少量具有免疫刺激活性的蛋白A泄漏。这或许可以解释治疗性免疫吸附后的坏死现象。